NCT04605003 is a NA clinical trial of Novel rig-S in Sterility, sponsored by Universiti Kebangsaan Malaysia Medical Centre.

Who is sponsoring NCT04605003?

NCT04605003 is sponsored by Universiti Kebangsaan Malaysia Medical Centre.

What drugs are being tested in NCT04605003?

Interventions in NCT04605003: Novel rig-S, Conventional Autoclave machine.

Is NCT04605003 still recruiting?

NCT04605003 is currently completed. Last updated 27 October 2020.

Last reviewed 2020-10-27 · How we verify

NCT04605003

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Nasal Endoscope Sterilization Using a Novel Rig-S™ Device

Completed NA Last updated 27 October 2020

What this trial tests

NA trial testing Novel rig-S in Sterility in 500 participants. Completed in 28 February 2020.

Timeline

1 October 2018

Primary endpoint
28 February 2020

28 February 2020

Quick facts

Lead sponsor	Universiti Kebangsaan Malaysia Medical Centre
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	500
Start date	1 October 2018
Primary completion	28 February 2020
Estimated completion	28 February 2020
Sites	1 location across Malaysia

Drugs / interventions tested

Novel rig-S
Conventional Autoclave machine

Conditions studied

Sterility — all drugs for Sterility →

Sponsor

Universiti Kebangsaan Malaysia Medical Centre — full company profile →

Who can join

18 and older, any sex, with Sterility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the sterility of rigid nasoendoscopies after being sterilized with a conventional autoclave machine and a novel rig-S device that uses standard high level disinfectant

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universiti Kebangsaan Malaysia Medical Centre trials

Trials by the same sponsor.

NCT07466485 — The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFL · Phase 2 · recruiting
NCT07041814 — A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRI · Phase 2 · not yet recruiting
NCT07000227 — Mechanism of FODMAP Restriction on FGID Patients · NA · recruiting
NCT05694858 — Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adu · Phase 1, PHASE2 · recruiting
NCT07447310 — Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04605003 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiti Kebangsaan Malaysia Medical Centre
Last refreshed: 27 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04605003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing